Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Support program for patients with unruptured intracranial aneurysms

Official title: Patients with Unruptured IntraCranial ANeurysms: Evaluation of the Benefits of Allied Health FollOw-uP in a RandomizEd Controlled Trial

Run by Nantes University Hospital · NCT06708078 · Data updated 2026-11-12

This study is testing a new support program to see if it helps people with unruptured intracranial aneurysms feel better and manage their condition more effectively.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment340 (estimated)
SponsorNantes University Hospital
Academic / other
Locations1 site (Nantes, Loire-Atlantique)
StatusRecruiting
StartedNovember 7, 2023
Main results expectedNovember 6, 2026
Study endsMay 6, 2028
Registry record updatedNovember 27, 2024
Trial IDNCT06708078 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 with newly diagnosed untreated intracranial aneurysms monitored by imaging.

Probably not a fit

Patients with a history of ruptured intracranial aneurysms or specific syndromes known to cause aneurysms may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The CANHOPE program aims to evaluate the benefits of an allied health support initiative for patients with untreated unruptured intracranial aneurysms. This interventional study employs a cluster randomized controlled trial design alongside a qualitative study to gather insights from patients and caregivers. The program is inspired by the uncertainty of illness theory and seeks to enhance patient management and quality of life through tailored support. By addressing the inadequacies in the current care pathway, the study aims to provide valuable data for clinicians and decision-makers.

Why it matters

Potential benefit: If successful, this program could significantly improve the quality of life and management of patients with unruptured intracranial aneurysms.

How similar studies have gone: While similar approaches have been explored, this specific program is novel in its focus on allied health support for unruptured intracranial aneurysms.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient with newly diagnosed (\<9 months) untreated Intracranial Aneurysm
* Patient with untreated Intracranial Aneurysm monitored by imaging
* Patient over 18
* Patient agreeing to participate in the study and having signed the consent form

Exclusion Criteria:

* Patient with a history of ruptured Intracranial Aneurysm
* Patient under guardianship or curatorship
* Patient diagnosed with a syndrome known to cause Intracranial Aneurysm :

  * Marfan syndrome
  * AOS (Aneurysm Osteoarthritis Syndrome) with SMAD 3 mutations
  * Type II and IV Elhers Danlos syndrome
  * Autosomal dominant polycystic fibrosis
  * Moya-Moya syndrome
* Patient with:

  * Dissecting or fusiform Intracranial Aneurysm
  * Intracranial Aneurysm associated with an arteriovenous malformation
  * Blister-like Intracranial Aneurysm
  * Mycotic Intracranial Aneurysm

Where it's running

  • CHU Nantes
    Nantes, Loire-Atlantique, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.